Neutral phosphate administration generates and maintains renal metabolic alkalosis and hyperparathyroidism.
We examined the effects of chronic intravenous neutral phosphate administration on systemic acid-base equilibrium and parathyroid function in six normal, NaCl-replete male human subjects under metabolic balance conditions. The subjects received 4.35 mmol of neutral sodium phosphate.kg body wt-1.day-1 intravenously and continuously for 7 days and the same amount of sodium as NaCl during control and recovery. Blood pH increased from 7.388 to 7.411 (P < 0.001) and plasma bicarbonate from 23.5 to 26.0 mmol/l (P < 0.001). Urinary pH increased from 6.58 to 6.79 (P < 0.001). Net acid excretion increased from 59 to 100 mmol/24 h (P < 0.001). Plasma ionized calcium concentration decreased and plasma phosphate concentration increased transiently. Serum intact parathyroid hormone increased from 24 to 62 pg/ml (P < 0.001). Chronic phosphate administration also resulted in a significant increase in renal phosphate clearance (35 to 229 ml/min) and decrease in the fractional excretion of calcium (1.8 to 0.9%). Thus chronic intravenous phosphate administration generates and maintains renal metabolic alkalosis in salt-replete humans and induces hyperparathyroidism. The severity of metabolic alkalosis is mitigated by an apparent increase in effective endogenous acid production as evidenced by the significant increase in steady-state net acid excretion.
Krapf
R
R
Klinik B für Innere Medizin, Kantonsspital, St. Gallen, Switzerland.
Glatz
M
M
Hulter
H N
HN
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000328:Adult; D000471:Alkalosis / Q000097:blood / Q000139:chemically induced* / Q000652:urine; D006801:Humans; D006961:Hyperparathyroidism / Q000139:chemically induced*; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced* / Q000652:urine; D008297:Male; D010710:Phosphates / Q000494:pharmacology
D010710:Phosphates